Daily intake of low-dose aspirin did not lower risk of dying from cancer or heart disease, but it did reduce first heart attack or stroke by 10%, according to an analysis of nine trials involving more than 102,000 participants. U.K. researchers also found that daily low-dose aspirin therapy put patients at risk for serious bleeding events. "Taken in the aggregate, the modest benefit of aspirin on patients without established cardiovascular disease has to be carefully balanced against the excess risk caused by the therapy," according to NYU's Dr. Jeffrey Berger, who was not involved in the study.

Full Story:
HealthDay News

Related Summaries